DK120812B - Fremgangsmåde til fremstilling af et stabilt farmaceutisk præparat på grundlag af østronsulfat og østradiol-3-sulfat. - Google Patents

Fremgangsmåde til fremstilling af et stabilt farmaceutisk præparat på grundlag af østronsulfat og østradiol-3-sulfat.

Info

Publication number
DK120812B
DK120812B DK464068AA DK464068A DK120812B DK 120812 B DK120812 B DK 120812B DK 464068A A DK464068A A DK 464068AA DK 464068 A DK464068 A DK 464068A DK 120812 B DK120812 B DK 120812B
Authority
DK
Denmark
Prior art keywords
sulphate
estradiol
preparation
pharmaceutical composition
composition based
Prior art date
Application number
DK464068AA
Other languages
Danish (da)
English (en)
Inventor
Lucari G Hecht
H Kraft
W Mehrhof
K Irmscher
H Kieser
Original Assignee
Merck Ag E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19671617654 external-priority patent/DE1617654A1/de
Application filed by Merck Ag E filed Critical Merck Ag E
Publication of DK120812B publication Critical patent/DK120812B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK464068AA 1967-10-19 1968-09-26 Fremgangsmåde til fremstilling af et stabilt farmaceutisk præparat på grundlag af østronsulfat og østradiol-3-sulfat. DK120812B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19671617654 DE1617654A1 (de) 1967-10-19 1967-10-19 Arzneimittel

Publications (1)

Publication Number Publication Date
DK120812B true DK120812B (da) 1971-07-19

Family

ID=5682283

Family Applications (1)

Application Number Title Priority Date Filing Date
DK464068AA DK120812B (da) 1967-10-19 1968-09-26 Fremgangsmåde til fremstilling af et stabilt farmaceutisk præparat på grundlag af østronsulfat og østradiol-3-sulfat.

Country Status (9)

Country Link
US (1) US3639599A (en:Method)
BE (1) BE722511A (en:Method)
BR (1) BR6803213D0 (en:Method)
DK (1) DK120812B (en:Method)
ES (1) ES359336A1 (en:Method)
FR (1) FR7983M (en:Method)
GB (1) GB1175468A (en:Method)
IL (1) IL30594A (en:Method)
SE (1) SE365408B (en:Method)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2645307A1 (de) * 1976-10-05 1978-04-06 Schering Ag Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen
US4145416A (en) * 1976-06-23 1979-03-20 Schering, A.G. Novel agents and novel methods for treatment of climacteric disturbances
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
JPH0621072B2 (ja) * 1986-11-12 1994-03-23 呉羽化学工業株式会社 エストラジオ−ル誘導体よりなる免疫調節剤
US4946679A (en) * 1988-07-25 1990-08-07 Thys Jacobs Susan Method for the treatment of premenstrual syndrome
US5354743A (en) * 1992-09-15 1994-10-11 Thys Jacobs Susan Method for the treatment of premenstrual syndrome with vitamin D
AU2002338277B2 (en) * 2001-03-16 2007-11-22 Wyeth Estrogen replacement therapy
US20060040904A1 (en) * 2004-08-17 2006-02-23 Ahmed Salah U Vaginal cream compositions, kits thereof and methods of using thereof
US8217024B2 (en) * 2005-12-27 2012-07-10 Teva Women's Health, Inc. Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
US20080194533A1 (en) * 2007-02-09 2008-08-14 Wyeth Process for selective sulfation of aromatic hydroxyl groups

Also Published As

Publication number Publication date
FR7983M (en:Method) 1970-06-08
SE365408B (en:Method) 1974-03-25
ES359336A1 (es) 1970-07-01
BE722511A (en:Method) 1969-04-18
GB1175468A (en) 1969-12-23
BR6803213D0 (pt) 1973-04-26
US3639599A (en) 1972-02-01
IL30594A (en) 1972-05-30
IL30594A0 (en) 1968-10-24

Similar Documents

Publication Publication Date Title
DK122222B (da) Fremgangsmåde til fremstilling af alk-3-en-1-oler.
DK133783B (da) Fremgangsmåde til fremstilling af 7-halogen-7-desoxy-1-thio-alfa-D-galacto-octopyranosider.
DK120859B (da) Fremgangsmåde til fremstilling af et lægemiddelpræparat til lokal påføring og indeholdende en polymeremulsion.
DK124080B (da) Fremgangsmåde til fremstilling af D-6-metyl-8-cyanmetylergolin.
DK136059B (da) Analogifremgangsmåde til fremstilling af 5-aroyl-pyrrol-derivater og salte deraf.
DK127106B (da) Analogifremgangsmåde til fremstilling af basiske aryloxy-acetamider og syreadditionssalte deraf.
DK127725B (da) Analogifremgangsmåde til fremstilling af anthranilsyre- og nicotinsyrederivater.
DK117312B (da) Heterofilamenter og fremgangsmåde til fremstilling af samme.
IT1061738B (it) Composti 2-cicloalchil-eteroarilici e composizioni farmaceutiche contenenti tali composti
DK119307B (da) Fremgangsmåde til fremstilling af ketonitriler.
DK124536B (da) Analogifremgangsmåde til fremstilling af 4-aryl-3-hydroxybutyrohydroxamsyre.
DK117501B (da) Fremgangsmåde til fremstilling af d-lysergsyre-alkanol-amider.
DK122758B (da) Fremgangsmåde til fremstilling af α-methyl-multicyclo-methylaminer.
DK123100B (da) Fremgangsmåde til fremstilling af N-tritylimidazoler.
DK117832B (da) Fremgangsmåde til fremstilling af ɛ-caprolactam og ω-decalactam.
DK118507B (da) Fremgangsmåde til fremstilling af 3-dimethylsulfamoylphenthiazinderivater.
DK127553B (da) Fremgangsmåde til fremstilling af susbstituerede salicylanilider og thiosalicylanilider.
DK112161B (da) Fremgangsmåde til fremstilling af et gærpræparat til farmaceutisk anvendelse.
DK131821B (da) Analogifremgangsmåde til fremstilling af en 2-karbalkoksyaminobenzimidazol.
DK123411B (da) Analogifremgangsmåde til fremstilling af N-substituerede 4-anilinopyridiner og syreadditionssalte deraf.
DK119976B (da) Analogifremgangsmåde til fremstilling af 18-methyl-19-nor-17α-hydroxyprogesteroner og -17-estere deraf.
DK123476B (da) Fremgangsmåde til fremstilling af 3-oxo-A-nor-B-homo-estra-5(10)-ener.
DK120948B (da) Fremgangsmåde til fremstilling af (androst-17β-yl)-α-pyroner.
DK120744B (da) Fremgangsmåde til fremstilling af steroidbutenolider.
DK120335B (da) Analogifremgangsmåde til fremstilling af 2-undecenyl-2-isothiourinstof og syreadditionssalte deraf.